Schizophrenia is not a very common disease but it can be serious and chronic. Worldwide, about 1 percent of the population is diagnosed with schizophrenia, and approximately 1.2% of Americans (3.5 million people) suffer from the disorder. Treatment and other economic costs due to schizophrenia are enormous, estimated between $32.5 and $65 billion annually.
Schizophrenia is an incredibly complex disorder that has been linked to a collection of different disorders. It is known that the disease progresses over time with full psychosis at a late stage of the disorder. Thus, early and extreme interventions and therapies give hope for better results in the long term. That is why early diagnosis is crucial for schizophrenia.
Researchers can run a full-connectomics pipeline on Mint Labs platform to detect connectivity abnormalities, which is common in schizophrenia patients. This can support the intense research going on in the medical field.